Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension in pregnancy.

P Maikranz, M D Lindheimer

    The Medical Clinics of North America
    |September 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    This review discusses hypertensive disorders in pregnancy, particularly pre-eclampsia. It advocates for a balanced management approach to ensure a healthy pregnancy outcome without long-term maternal health issues.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    L24. The meaning of proteinuria in preeclampsia.

    Pregnancy hypertension·2015
    Same author

    Avoiding the eclamptic convulsion.

    BJOG : an international journal of obstetrics and gynaecology·2014
    Same author

    PIERS proteinuria: relationship with adverse maternal and perinatal outcome.

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2011
    Same author

    Reference values for clinical chemistry tests during normal pregnancy.

    BJOG : an international journal of obstetrics and gynaecology·2008
    Same author

    Connexin expression is not altered in omental resistance vessels from women with preeclampsia.

    Hypertension in pregnancy·2002
    Same author

    The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP).

    Hypertension in pregnancy·2002
    Same journal

    Care Transitions Continue to Evolve.

    The Medical clinics of North America·2026
    Same journal

    Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

    The Medical clinics of North America·2026
    Same journal

    Care Transitions and Value-Based Payment Models in the United States.

    The Medical clinics of North America·2026
    Same journal

    Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

    The Medical clinics of North America·2026
    Same journal

    Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

    The Medical clinics of North America·2026
    Same journal

    Social Determinants of Health: Unique Considerations in Transitions of Care.

    The Medical clinics of North America·2026
    See all related articles

    Area of Science:

    • Obstetrics and Gynecology
    • Maternal-Fetal Medicine
    • Hypertensive Disorders of Pregnancy

    Background:

    • Hypertensive complications of pregnancy represent a significant clinical challenge.
    • Pre-eclampsia, a major hypertensive disorder, is characterized by limited data and ongoing scientific debate regarding its pathophysiology and optimal management.

    Purpose of the Study:

    • To review the current understanding of hypertensive complications in pregnancy.
    • To focus on the pathophysiology and management strategies for pre-eclampsia.
    • To propose an intermediate management approach balancing maternal and fetal well-being.

    Main Methods:

    • Literature review of existing data on hypertensive disorders in pregnancy.
    • Analysis of the pathophysiology of pre-eclampsia.

    Related Experiment Videos

  • Evaluation of current management strategies and their outcomes.

    • Main Results:

    • Significant gaps in data and considerable expert disagreement exist regarding pre-eclampsia.
    • Current management often involves balancing the risks of the condition against the risks of intervention.
    • An intermediate approach is proposed to optimize pregnancy outcomes.

    Conclusions:

    • Effective management of pre-eclampsia requires addressing data limitations and resolving scientific disagreements.
    • An intermediate therapeutic strategy aims for successful pregnancy completion.
    • The proposed approach prioritizes preventing residual maternal pathology post-delivery.